Results 31 to 40 of about 1,821 (152)

Relationship of the intensity of physical performance and sedentary time with uric acid in patients with type 2 diabetes

open access: yesJournal of Diabetes Investigation, Volume 16, Issue 9, Page 1733-1741, September 2025.
High uric acid (UA) facilitates diabetes progression and is responsible for developing other diseases, such as cardiovascular disease and renal disease. Lifestyle modifications could lower UA levels, but relevant evidence is required in patients with type 2 diabetes.
Jie Li, Ertao Zhang, Zhao Dong, Yan Liu
wiley   +1 more source

Advances in Xanthine Oxidase Inhibition: A Review of Potential Bioactive Synthetic Compounds

open access: yesArchiv der Pharmazie, Volume 358, Issue 8, August 2025.
This review article looks at new synthetic xanthine oxidase inhibitors discovered in the last 5 years (2025–2020). It covers an analysis of the advances, structural diversity, biological potential of the molecules investigated and future prospects in drug development.
Giorgio Antoniolli   +4 more
wiley   +1 more source

Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub‐analysis of the EMPAG‐HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure)

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 8, Page 1472-1478, August 2025.
Effects of empagliflozin on uric acid levels during acute heart failure recompensation. Abstract Background Sodium–glucose cotransporter 2 inhibitors improve prognosis in chronic heart failure as part of currently recommended therapeutic strategies.
Jurgen Bogoviku   +7 more
wiley   +1 more source

Management of hyperuricemia in gout: focus on febuxostat

open access: yesClinical Interventions in Aging, 2010
Mattheus K Reinders1, Tim L Th A Jansen21Clinical Pharmacy, Atrium Medisch Centrum Parkstad, Heerlen, The Netherlands; 2Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The NetherlandsAbstract: Gout is the most common inflammatory arthritis in an ...
Mattheus K Reinders, Tim L Th A Jansen
doaj  

2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common Comorbidities

open access: yesInternational Journal of Rheumatic Diseases, Volume 28, Issue 8, August 2025.
ABSTRACT Objective The aim of this updated guideline is to provide comprehensive recommendations for the management of gout in patients with common comorbidities, such as chronic kidney disease (CKD), cardiovascular disease (CVD), diabetes, osteoarthritis (OA), and gastrointestinal disorders.
Changgui Li   +30 more
wiley   +1 more source

Critical appraisal of the role of pegloticase in the management of gout

open access: yesOpen Access Rheumatology: Research and Reviews, 2012
Hang-Korng Ea,1,2 Pascal Richette1,21Hôpital Lariboisière, Rheumatology Department, Paris, France; 2University of Paris Diderot, Sorbonne Paris Cité, Paris, FranceAbstract: Gout is a debilitating disease secondary to ...
Ea HK, Richette P
doaj  

Assessing gout risk associated with GLP‐1 therapy in obese patients with type 2 diabetes: A retrospective cohort study

open access: yes
Rheumatology &Autoimmunity, Volume 5, Issue 3, Page 238-240, September 2025.
Justin Riley Lam   +6 more
wiley   +1 more source

Uricosuric Agents in the Treatment of Gout [PDF]

open access: yesAnnals of the Rheumatic Diseases, 1960
G D, KERSLEY, A R, GIBBS
openaire   +2 more sources

Home - About - Disclaimer - Privacy